Wendy Chapman serves as Executive at ProNAi Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Wendy Chapman has executed 6 insider transactions totaling $89.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 22, 2016 involved exercising options for 3,000 shares valued at $2.9K.
Wendy Chapman currently holds 3,000 shares of ProNAi Therapeutics Inc (DNAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy Chapman has been a net seller of DNAI stock. They have purchased $0 and sold $89.2K worth of shares.
Wendy Chapman's most recent insider trade was on Mar 22, 2016, when they sold 3,000 shares at $0.97 per share.
Get notified when new Form 4 filings are submitted
| $7.01 |
| Discretionary |
| Feb 22, 2016 | DNAI | $21.2K | Sale | 3,000 | $7.06 | Discretionary |
| Feb 22, 2016 | DNAI | $2.9K | Option Exercise | 3,000 | $0.97 | Discretionary |
| Jan 22, 2016 | DNAI | $47.0K | Sale | 5,000 | $9.39 | Discretionary |
| Jan 22, 2016 | DNAI | $4.8K | Option Exercise | 5,000 | $0.97 | Discretionary |